This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: California Institute of Technology, The Weizmann Institute of Science. Active years: 2025.
Company Filing History:


Years Active: 2025
Title: Sarel J Fleishman: Innovator in Bacterial Viability Interference
Introduction
Sarel J Fleishman is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of microbiology, particularly in the development of methods to interfere with the viability of bacteria. His innovative work has implications for antibiotic resistance and bacterial infections.
Latest Patents
Fleishman's most recent patent is titled "Pyocyanine demethylases and related phenazine degrading agents compositions, methods and systems for interfering with viability of bacteria." This patent describes engineered pyocyanin demethylases with specific replacements in various positions of the pyocyanin demethylase PodA. The invention also includes related phenazine degrading agents and methods for their combined administration with antibiotics, resulting in a synergistic inhibition of phenazine-producing bacteria.
Career Highlights
Throughout his career, Sarel J Fleishman has worked with prestigious institutions such as the California Institute of Technology and Yeda Research and Development Company at the Weizmann Institute of Science. His research has focused on the intersection of biochemistry and microbiology, leading to advancements in understanding bacterial behavior and treatment.
Collaborations
Fleishman has collaborated with esteemed colleagues, including Dianne K Newman and Chelsey M VanDrisse. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Sarel J Fleishman's contributions to the field of microbiology through his innovative patents and collaborations highlight his role as a key figure in the fight against bacterial infections. His work continues to influence the development of new therapeutic strategies.